HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young-Sik Jung Selected Research

1- (4- carbamoylpyridinium)- 4- (3- fluoro- 4- hydroxyiminomethylpyridinium)- but- 2- ene

11/2010A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
8/2010A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young-Sik Jung Research Topics

Disease

6Poisoning
01/2021 - 01/2008
3Organophosphate Poisoning
01/2021 - 07/2009
3Human Influenza (Influenza)
10/2016 - 11/2013
2Mitochondrial Diseases (Mitochondrial Disease)
07/2014 - 02/2014
1Severe Acute Respiratory Syndrome
01/2021
1Hepatitis B
02/2020
1Chronic Disease (Chronic Diseases)
01/2017
1Infections
10/2016
1Ataxia Telangiectasia (Louis Bar Syndrome)
07/2014
1Ototoxicity
02/2014
1Virus Diseases (Viral Diseases)
10/2013
1Alzheimer Disease (Alzheimer's Disease)
11/2011
1Myasthenia Gravis
03/2010

Drug/Important Bio-Agent (IBA)

6OximesIBA
01/2021 - 01/2008
5tabunIBA
03/2011 - 01/2008
2Antiviral Agents (Antivirals)IBA
01/2017 - 10/2016
2Proteins (Proteins, Gene)FDA Link
10/2016 - 07/2014
2Viral ProteinsIBA
10/2016 - 07/2014
2Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2011 - 03/2010
2AcetylcholinesteraseIBA
03/2011 - 03/2010
2CarbamatesIBA
01/2011 - 03/2010
2Obidoxime Chloride (Obidoxime)IBA
11/2010 - 01/2008
21- (4- carbamoylpyridinium)- 4- (3- fluoro- 4- hydroxyiminomethylpyridinium)- but- 2- eneIBA
11/2010 - 08/2010
1Organophosphorus CompoundsIBA
01/2021
1Protease Inhibitors (Protease Inhibitor)IBA
01/2021
1SulfonamidesIBA
02/2020
15,6- dimethyl- 3H,3'H- spiro(benzofuran- 2,1'- isobenzofuran)- 3,3'- dioneIBA
10/2016
1NucleoproteinsIBA
10/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2014
1Organic Chemicals (Chemicals, Organic)IBA
07/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2014
1Cisplatin (Platino)FDA LinkGeneric
02/2014
1Protective AgentsIBA
02/2014
13- amino- 3- (4- fluorophenyl)- 1H- quinoline- 2,4- dioneIBA
02/2014
1Viral RNAIBA
11/2013
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2013
1Pharmaceutical PreparationsIBA
10/2013
1Tacrine (Cognex)FDA Link
11/2011
11- (4- carbamoylpyridinium)- 3- (4- hydroxyiminomethylpyridinium)- 2- oxapropaneIBA
03/2011
1BromidesIBA
01/2011
1AtropineFDA LinkGeneric
11/2010
1Paraoxon (E600)IBA
09/2010
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2010
1Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
03/2010
1Neostigmine (Neostigmine Bromide)IBA
03/2010
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2010
1ButyrylcholinesteraseIBA
07/2009
1AntidotesIBA
07/2009
1Trimedoxime (Trimedoxime Bromide)IBA
01/2008

Therapy/Procedure

1Therapeutics
01/2017
1Radiotherapy
07/2014